Linder 2000.
Methods |
Study design: open‐label, randomised trial Setting: Neonatal Division, Department of Pediatrics, Kalawati Saran Children's Hospital, Delhi, India Study dates: June to December 1994 |
|
Participants |
Sample size: 177 infants (127 preterm infants and 50 full‐term infants) Dropouts/withdrawals: 40 children (22 = received blood products, 3 preterm infants = with sepsis, and 15 full‐term infants = withdrawn by their parents after the first blood test) Age: neonates (preterm experimental group median age = 32 weeks, full‐term control group = 40 weeks, preterm control group = 32 weeks) Sex: male = 62, female = 75 Inclusion criteria: preterm infants born between June and December 1994 (gestational age 30–35 weeks, weight > 1000 g); Fifty healthy full‐term infants (gestational age > 37 weeks, weight > 2500 g), born consecutively in the morning hours between 1 June 1994 and 15 June 1994. Exclusion criteria: not reported |
|
Interventions |
Preterm experimental? group (n = 50): II (I + O) O at birth, 2, 4 and 6 months Full‐term group (n = 50): I (I + O) O at 2, 4 and 6 months Preterm group (n = 52): I (I + O) O at 2, 4 and 6 months Fifty preterm infants received IPV intramuscularly within 24 hours of birth, in addition to routine recommended childhood immunisations. Fifty‐two preterm infants and 35 full‐term infants received routine immunisations only (routine vaccination timing: HBV at birth, 1 and 6 months of age; IPV at 2 and 4 months; oral polio vaccine (OPV) at 4 and 6 months; diphtheria‐tetanus‐ pertussis (DTP) at 2, 4, and 6 months; and Haemophilus influenzae B vaccine at 2 and 4 months). Blood samples were taken at birth, 3 and 7 months of age from all infants, and at 1 month of age from preterm infants only. |
|
Outcomes |
Timing of outcome assessment: 7 months Follow‐up: 7 months |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk |
Quote: "The preterm infants were divided into a study group (group A; n = 50) and a control group (group B; n = 52) by 1:1 randomisation..." Comment: probably done properly, since the table of baseline characteristics of randomised participants is balanced |
Allocation concealment (selection bias) | Low risk | Quote: "...using a blinded envelope drawn by the parents. All full term infants were included in control group C." |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Comment: no blinding but performance is not likely to be influenced by lack of blinding in terms of intervention or co‐interventions |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Comment: no blinding but the objective outcome (antibody titres) is not likely to be influenced by lack of blinding |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Comment: no lost to follow‐up. At the bottom of Table 5 "A, group A (n = 50); B, group B (n = 52); C, group C (n = 35)" (quote) |
Selective reporting (reporting bias) | Low risk | Comment: no evidence of selecting reporting |
Other bias | Low risk | Comment: no evidence of other bias |
Conflict of interest | Low risk | Comment: this study was supported by the chief scientist of the Israel Ministry of Health. |